期刊文献+

卡介菌多糖核酸与曲安奈德治疗溃疡型口腔扁平苔藓疗效比较 被引量:3

Observation on the therapeutic effect of BCG-PSN and triamcinolone acetonide on ulcerative oral lichen planus
原文传递
导出
摘要 目的评价卡介菌多糖核酸与曲安奈德治疗溃疡型口腔扁平苔藓(OLP)的疗效。方法选择2008年11月至2009年9月南阳市口腔医院黏膜科溃疡型OLP患者31例,随机分为卡介菌多糖核酸组(16例)与曲安奈德组(15例)。分别于口腔病损部位黏膜下封闭注射卡介菌多糖核酸和曲安奈德,每周1次,4~6次为1个疗程。随访6个月,观察疗效及复发情况。结果治疗1个疗程后,卡介菌多糖核酸组治疗总有效率为87.5%,曲安奈德组治疗总有效率为73.3%,二者差异无统计学意义;随访6个月,卡介菌多糖核酸组总复发率为50.0%,曲安奈德组总复发率为90.9%,两组差异有统计学意义(P<0.05)。结论局部采用卡介菌多糖核酸和曲安奈德封闭治疗溃疡型OLP均疗效显著,卡介菌多糖核酸治疗后复发少于曲安奈德。 Objective To evaluate the therapeutic effect of BCG-PSN and triamcinolone acetonide on ulcerative oral lichen planus(OLP). Methods From November 2008 to September 2009,Department of Periodontal and Oral Mucosal Disease,Nanyang Stomatological Hospital,31 patients with ulcerative OLP were chosen and randomly divided into BCG-PSN group(16 cases)and triamcinolone acetonide group(15 cases). The patients were given closed injection of BCG-PSN and triamcinolone acetonide under oral submucous lesion site respectively,once a week,4 to 6 times for a course of treatment. Observe the efficacy and recurrence after 6-month follow-up. Results After a course of treatment,total effective rate in BCG-PSN group was 87.5%,and that of triamcinolone acetonide group was 73.3%,the difference being not statistically significant. After 6 months the total recurrence rate of BCG-PSN group was 50.0%,and in triamcinolone acetonide group it was 90.9%,being with significant difference. Conclusion Partial closure of BCG-PSN and triamcinolone acetonide treatment for ulcerative OLP has significant effect,and the relapse rate is lower in the BCG-PSN group than in the triamcinolone acetonide group.
出处 《中国实用口腔科杂志》 CAS 2009年第12期747-748,共2页 Chinese Journal of Practical Stomatology
关键词 口腔扁平苔藓 局部封闭 卡介菌多糖核酸 曲安奈德 oral lichen planus partial closure BCG-PSN triamcinolone acetonide
  • 相关文献

参考文献3

二级参考文献30

  • 1于世凤,章魁华,庞淑珍.关于扁平苔藓性质的探讨[J].现代口腔医学杂志,1994,8(1):18-19. 被引量:13
  • 2常敏,李秉琦.口腔扁平苔藓的免疫治疗现状[J].口腔医学,1995,15(1):51-52. 被引量:34
  • 3[1]Scully C, Beyli M, Ferreiro MC,et al.Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med,1998,9(1)∶86-122
  • 4[2]Mollaoglu N.Oral lichen planus: a review. Br J Oral Maxillofac Surg,2000,38(4)∶370-377
  • 5[3]McCartan BE,McCreary CE. What is the rationale for treating oral lichen planus? Oral Dis,1995,5∶181-182
  • 6[4]McCreary CE,McCartan BE. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg,1999,37∶338-343
  • 7[5]Carrozzo M,Gandolfo S. The management of oral lichen planus. Oral Dis,1999,5∶196-205
  • 8[6]McCartan BE, Jontell M, Jungell P. Oral Lichen planus and lichenoid reactions. Oral Dis,1997,3∶43-44
  • 9[7]Thongprasom K,Luangjarmekorn L, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med,1992,21∶456-458
  • 10[8]Voute ABE, Schulten EAJM, Langendijk PNJ,et al. Fluocinonide in an adhesive base for treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol,1993,75∶181-185

共引文献33

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部